Abstract
In 2017, the Montreux diagnostic criteria for neonatal acute respiratory distress syndrome(ARDS) were released, which helps to decrease neonatal mortality and morbidity and the incidence of sequelae.However, how to use the diagnostic criteria remains confused for the neonatologists for its ambiguity of definition in clinical risk factors, differentiating from premature respiratory distress syndrome, and relationship between surfactant and neonatal ARDS.In the present review, these issues will be focused to better interpret and use the definition in dealing with neonatal ARDS. Key words: Acute respiratory distress syndrome; Pulmonary surfactant; Infant, newborn; Infant, preterm
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.